Please ensure Javascript is enabled for purposes of website accessibility Growth and Income Fund - Janus Henderson Investors
For Individual Investors in the US

Growth and Income Fund Holdings

Full Portfolio Holdings

(As of May 31, 2024)

% OF INVESTMENTS
Microsoft Corp 10.58
Apple Inc 4.64
KLA Corp 3.90
Accenture PLC 3.67
JPMorgan Chase & Co 3.21
Visa Inc 3.07
American Express Co 2.95
UnitedHealth Group Inc 2.78
Meta Platforms Inc 2.66
Alphabet Inc 2.55
Texas Instruments Inc 2.55
Eli Lilly & Co 2.07
McDonald's Corp 2.05
Broadcom Inc 1.90
Procter & Gamble Co 1.88
NIKE Inc 1.77
Oracle Corp 1.76
Abbott Laboratories 1.75
Deere & Co 1.72
CME Group Inc 1.70
Morgan Stanley 1.65
Applied Materials Inc 1.60
Lam Research Corp 1.59
Automatic Data Processing Inc 1.56
Honeywell International Inc 1.50
Chevron Corp 1.50
Marriott International Inc/MD 1.48
AbbVie Inc 1.44
Home Depot Inc 1.38
Merck & Co Inc 1.38
General Dynamics Corp 1.35
Medtronic PLC 1.34
Hershey Co 1.16
TJX Cos Inc 1.15
Analog Devices Inc 1.13
Marsh & McLennan Cos Inc 1.09
Booking Holdings Inc 1.09
International Business Machines Corp 1.07
Trane Technologies plc 0.98
Zoetis Inc 0.93
Danaher Corp 0.87
Sysco Corp 0.85
Charles Schwab Corp 0.84
Costco Wholesale Corp 0.83
HCA Healthcare Inc 0.82
Booz Allen Hamilton Holding Corp 0.81
Gilead Sciences Inc 0.81
Intuit Inc 0.79
Constellation Brands Inc 0.76
ConocoPhillips 0.74
Stryker Corp 0.74
Goldman Sachs Group Inc 0.70
Walt Disney Co 0.69
Eaton Corp PLC 0.68
Schlumberger NV 0.64
Waste Management Inc 0.61
Corteva Inc 0.60
Amgen Inc 0.58
Moody's Corp 0.40
Motorola Solutions Inc 0.35
Cash & Equivalents 0.36
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.